When collected at a broad scale, data can be used to address all sorts of problems — including diseases.
Healthtech startup Komodo Health analyzes information about diseases from hundreds of millions of patients to deliver insights that can be used by life science companies, healthcare payers and providers, patient advocacy groups and more.
On Wednesday, the company announced the closing of its $50 million Series C led by Andreessen Horowitz. This funding will help Komodo Health build new software, in addition to expanding its Healthcare Map.
The company’s Healthcare Map acts as a central database for healthcare data from patients across the country. It records over 15 million new patient encounters every day to provide a detailed view about how people are interacting with their healthcare providers.
“Our platform is designed to drive better health outcomes for patients by harnessing the power of more than 320 million longitudinal healthcare experiences,” Arif Nathoo, MD, Komodo Health’s CEO and co-founder, said in a statement. “Built on this wealth of knowledge, our technology delivers the insights needed to detect disparities in care delivery, identify interventions, and ultimately make a material difference in patient outcomes.”
This data could prove very valuable to professionals in the industry. The company claims it can “pinpoint geographic disparities in care delivery, and then drive intervention at the healthcare provider level to improve quality and outcomes for patients.”
“Despite the ongoing digitization of care delivery, fragmented information and challenges with healthcare data interoperability have thwarted efforts to drive better outcomes for patients. As the company expands, Komodo’s unique platform will drive innovation across the healthcare ecosystem to reduce the burden of disease,” Komodo Health president and co-founder, Web Sun said in a statement.
While Komodo Health originally started in a basement, the company now has about 220 employees and offices in San Francisco and New York City.
